SPIDOL study protocol for the assessment of intrathecal ziconotide antalgic efficacy for severe refractory neuropathic pain due to spinal cord lesions
Abstract Rationale Central neuropathic pain resulting from spinal cord injury is notoriously debilitating and difficult to treat with few currently available treatments. A novel molecule with intrathecal administration: Ziconotide has been approved for treatment of refractory neuropathic pain in gen...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2024-09-01
|
| coleção: | Trials |
| Acesso em linha: | https://doi.org/10.1186/s13063-024-08387-0 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|